Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
Preferred Name | zafirlukast | |
Synonyms |
Olmoran 4-(5-cyclopentyloxycarbonylamino-2-methylindol-3-yl-methyl)-3-methoxy-N-O-tolylsulfonylbenzamide Accolate ICI 204219 ICI 204,219 ICI-204219 Aeronix |
|
ID |
http://purl.bioontology.org/ontology/MESH/C062735 |
|
altLabel |
Olmoran 4-(5-cyclopentyloxycarbonylamino-2-methylindol-3-yl-methyl)-3-methoxy-N-O-tolylsulfonylbenzamide Accolate ICI 204219 ICI 204,219 ICI-204219 Aeronix
|
|
cui |
C1529264 C0378466 C0526503 C1529265 C0526502
|
|
HM |
D007211 D048448 D013449
|
|
Inverse of RB |
XZ629S5L50 0
|
|
isa | ||
LT |
TRD
|
|
Mapped to |
http://purl.bioontology.org/ontology/MESH/D013449 |
|
MDA |
19900305
|
|
MeSH Frequency |
411
|
|
MMR |
20210504
|
|
notation |
C062735
|
|
PA |
D020024 D018927
|
|
prefLabel |
zafirlukast
|
|
RR |
107753-78-6 (zafirlukast)
|
|
SC |
1
|
|
Scope Statement |
a leukotriene D4 receptor antagonist
|
|
SRC |
J Pharmacol Exp Ther 1990;252(1):77
|
|
TERMUI |
T203495 T203494 T620719 T620721 T203499 T203497 T203498 T203496
|
|
TH |
US MX UK CA NLM (1990) FDA SRS (2017) ES INN (19XX) AU IE
|
|
tui |
T109 T121
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping